C3 and systemic lupus erythematosus: To test whether low C3 levels were temporally associated with SBI in our cohort, we next utilized every C3 measurement for the SLE/CTD patients as a new observation (n = 1150) and assessed the 30-day probability of having an SBI based upon C3 level as a continuous variable (Fig. 1).